Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 6 studies | 37% ± 20% | |
| oligodendrocyte | 6 studies | 30% ± 8% | |
| endothelial cell | 5 studies | 23% ± 9% | |
| astrocyte | 5 studies | 31% ± 9% | |
| oligodendrocyte precursor cell | 5 studies | 30% ± 11% | |
| interneuron | 5 studies | 36% ± 23% | |
| glutamatergic neuron | 4 studies | 55% ± 19% | |
| microglial cell | 3 studies | 19% ± 2% | |
| transit amplifying cell | 3 studies | 21% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 41% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1176.00 | 1444 / 1445 | 100% | 5.93 | 183 / 183 |
| brain | 100% | 1305.21 | 2639 / 2642 | 100% | 6.08 | 705 / 705 |
| prostate | 100% | 1384.39 | 245 / 245 | 99% | 4.47 | 498 / 502 |
| breast | 100% | 1560.13 | 459 / 459 | 99% | 5.69 | 1107 / 1118 |
| ovary | 100% | 1879.00 | 180 / 180 | 98% | 3.38 | 423 / 430 |
| pancreas | 100% | 1192.91 | 328 / 328 | 98% | 3.22 | 175 / 178 |
| lung | 99% | 1100.67 | 571 / 578 | 99% | 3.64 | 1145 / 1155 |
| intestine | 100% | 1377.24 | 966 / 966 | 98% | 4.31 | 515 / 527 |
| thymus | 100% | 1729.58 | 653 / 653 | 97% | 3.59 | 589 / 605 |
| stomach | 100% | 1285.85 | 359 / 359 | 97% | 4.79 | 278 / 286 |
| uterus | 100% | 1680.95 | 170 / 170 | 97% | 3.28 | 443 / 459 |
| kidney | 100% | 1021.87 | 89 / 89 | 95% | 4.04 | 859 / 901 |
| adrenal gland | 100% | 1404.98 | 258 / 258 | 95% | 3.82 | 219 / 230 |
| bladder | 100% | 1349.52 | 21 / 21 | 94% | 3.21 | 474 / 504 |
| skin | 100% | 2265.45 | 1809 / 1809 | 92% | 3.64 | 433 / 472 |
| liver | 98% | 577.67 | 222 / 226 | 70% | 1.52 | 286 / 406 |
| spleen | 100% | 1300.25 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.07 | 1 / 1 |
| adipose | 100% | 1381.56 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1309.18 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 786.26 | 796 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 884.02 | 844 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 3.16 | 44 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 72% | 1.84 | 21 / 29 |
| eye | 0% | 0 | 0 / 0 | 66% | 1.62 | 53 / 80 |
| peripheral blood | 33% | 516.34 | 311 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0060049 | Biological process | regulation of protein glycosylation |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0006486 | Biological process | protein glycosylation |
| GO_0006493 | Biological process | protein O-linked glycosylation |
| GO_0007399 | Biological process | nervous system development |
| GO_0046329 | Biological process | negative regulation of JNK cascade |
| GO_0007517 | Biological process | muscle organ development |
| GO_0035269 | Biological process | protein O-linked mannosylation |
| GO_0005615 | Cellular component | extracellular space |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005801 | Cellular component | cis-Golgi network |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005634 | Cellular component | nucleus |
| GO_0016780 | Molecular function | phosphotransferase activity, for other substituted phosphate groups |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FKTN |
| Protein name | Ribitol-5-phosphate transferase Ribitol-5-phosphate transferase FKTN (EC 2.7.8.-) (Fukutin) (Fukuyama-type congenital muscular dystrophy protein) (Ribitol-5-phosphate transferase) Fukutin |
| Synonyms | FCMD |
| Description | FUNCTION: Catalyzes the transfer of a ribitol-phosphate from CDP-ribitol to the distal N-acetylgalactosamine of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1) . This constitutes the first step in the formation of the ribitol 5-phosphate tandem repeat which links the phosphorylated O-mannosyl trisaccharide to the ligand binding moiety composed of repeats of 3-xylosyl-alpha-1,3-glucuronic acid-beta-1 . Required for normal location of POMGNT1 in Golgi membranes, and for normal POMGNT1 activity . May interact with and reinforce a large complex encompassing the outside and inside of muscle membranes . Could be involved in brain development (Probable). . |
| Accessions | A0A6Q8PHN1 ENST00000675668.1 ENST00000644273.1 ENST00000674633.1 A0A1B1PFW2 ENST00000357998.10 [O75072-1] ENST00000642952.1 ENST00000676192.1 A0A2R8YDW9 ENST00000676310.1 A0A6Q8PF14 ENST00000448551.6 [O75072-2] A0A6Q8PGS8 ENST00000374705.5 A0A6Q8PGV4 ENST00000457847.1 H7C3W5 I6L9J5 ENST00000642644.1 R4GMU0 A0A2R8Y768 ENST00000675695.1 ENST00000645933.1 ENST00000675443.1 ENST00000642537.1 A0A6Q8PG93 A0A6Q8PEY6 A0A2R8Y4L5 A0A6Q8PG65 ENST00000602661.6 ENST00000675232.1 ENST00000642177.1 A0A2R8Y6X6 ENST00000675736.1 ENST00000602526.1 ENST00000223528.6 [O75072-1] I7HPB4 O75072 ENST00000674563.1 ENST00000674767.1 ENST00000676371.1 A0A2R8Y7E3 |
